Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02514928
What this trial is testing

Resection of the Nerve Plexus on the Right Half of Celiac and SMA Associated With Extended Pancreatoduodenectomy in the Surgical Treatment for Adenocarcinoma of the Head of Pancreas

Who this might be right for
Pancreatic Cancer
Fudan University 430
Testing effectiveness (Phase 2)Study completedNCT00003769
What this trial is testing

Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Indiana University
Testing effectiveness (Phase 2)Study completedNCT00601627
What this trial is testing

Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 52
Large-scale testing (Phase 3)Looking for participantsNCT06861088
What this trial is testing

The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

Who this might be right for
Venous ThromboembolismMetastatic Pancreatic CancerLocally Advanced Pancreatic Adenocarcinoma
Quercis Pharma AG 480
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07097064
What this trial is testing

Evaluation of the Stereotactic MR-guided Adaptive Radiotherapy for Locally Advanced Pancreatic Cancers

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 160
Early research (Phase 1)Study completedNCT02166255
What this trial is testing

APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaRecurrent Pancreatic CancerRecurrent Renal Cell Cancer+9 more
Wake Forest University Health Sciences 17
Testing effectiveness (Phase 2)Study completedNCT00377936
What this trial is testing

EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas

Who this might be right for
AdenocarcinomaMetastasisPancreas Neoplasms
MediGene 212
Testing effectiveness (Phase 2)Study completedNCT02907099
What this trial is testing

Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v6 and v7
M.D. Anderson Cancer Center 20
Early research (Phase 1)WithdrawnNCT03682744
What this trial is testing

CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+4 more
Sorrento Therapeutics, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00276744
What this trial is testing

Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 249
Testing effectiveness (Phase 2)Active Not RecruitingNCT04666740
What this trial is testing

Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaHomologous Recombination Deficiency (HRD)
Memorial Sloan Kettering Cancer Center 63
Large-scale testing (Phase 3)Study completedNCT01231347
What this trial is testing

QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Who this might be right for
Adenocarcinoma of the PancreasAdvanced Solid TumorsCancer+13 more
NantCell, Inc. 800
Not applicableUnknownNCT02607826
What this trial is testing

Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors

Who this might be right for
CholangiocarcinomaPancreatic Ductal AdenocarcinomaColorectal Cancer+3 more
University Hospital Tuebingen 298
Testing effectiveness (Phase 2)Study completedNCT00735917
What this trial is testing

Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IV Pancreatic Cancer
National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)UnknownNCT00005869
What this trial is testing

Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Not applicableStudy completedNCT00900094
What this trial is testing

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+4 more
University of Michigan Rogel Cancer Center 200
Early research (Phase 1)Ended earlyNCT04807972
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis

Who this might be right for
Pancreatic Cancer
AbbVie 40
Not applicableStudy completedNCT06481397
What this trial is testing

OSCAR I STUDY - The ONCObind CTC Removal Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
ExThera Medical Corporation 5
Testing effectiveness (Phase 2)Ended earlyNCT06478862
What this trial is testing

Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy

Who this might be right for
Cancer of OvaryPancreatic Ductal Adenocarcinoma
Lipomedix Pharmaceuticals Inc. 19
Not applicableLooking for participantsNCT06582342
What this trial is testing

Is the 3D-PANC MSP Model Superior to CT for Assessing Response to Neoadjuvant Treatment in PCA Patients?

Who this might be right for
Adenocarcinoma of the Pancreas
Fundación para la Investigación del Hospital Clínico de Valencia 70
Next Page